ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Pearson Plc Ord (PK)

Pearson Plc Ord (PK) (PSORF)

16.1666
0.00
(0.00%)
Closed 13 January 8:00AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
16.1666
Bid
14.84
Offer
16.99
Volume
3,394
0.00 Day's Range 0.00
11.80 52 Week Range 16.1666
Market Cap
Previous Close
16.1666
Open
-
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,696
Shares Outstanding
666,249,622
Dividend Yield
-
PE Ratio
22.81
Earnings Per Share (EPS)
0.57
Revenue
3.67B
Net Profit
378M

About Pearson Plc Ord (PK)

Pearson is an international media group providing newspaper, magazine and book publishing, on-line and software services and television programming. Co. operates through the following three business segments: Pearson Education, Financial Times (FT) Group, and the Penguin Group. Pearson Education inc... Pearson is an international media group providing newspaper, magazine and book publishing, on-line and software services and television programming. Co. operates through the following three business segments: Pearson Education, Financial Times (FT) Group, and the Penguin Group. Pearson Education includes electric school testing and marking, publishing for schools and colleges, and web-based student information system. Show more

Sector
Miscellaneous Publishing
Industry
Printing,publishing & Allied
Headquarters
London, Gbr
Founded
1897
Pearson Plc Ord (PK) is listed in the Miscellaneous Publishing sector of the OTCMarkets with ticker PSORF. The last closing price for Pearson (PK) was US$16.17. Over the last year, Pearson (PK) shares have traded in a share price range of US$ 11.80 to US$ 16.1666.

Pearson (PK) currently has 666,249,622 shares in issue. The market capitalisation of Pearson (PK) is US$10.77 billion. Pearson (PK) has a price to earnings ratio (PE ratio) of 22.81.

PSORF Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40.93666.1497045305315.2316.166615.07280215.36352248CS
121.666611.493793103414.516.166614.5169615.22437795CS
262.846621.370870870913.3216.166612.7127714.1658845CS
524.366637.005084745811.816.166611.885913.55376505CS
1567.824993.80462016148.341716.16667.99289610.31793804CS
2608.058699.39072520978.10816.16665.248525129.14020304CS

PSORF - Frequently Asked Questions (FAQ)

What is the current Pearson (PK) share price?
The current share price of Pearson (PK) is US$ 16.1666
How many Pearson (PK) shares are in issue?
Pearson (PK) has 666,249,622 shares in issue
What is the market cap of Pearson (PK)?
The market capitalisation of Pearson (PK) is USD 10.77B
What is the 1 year trading range for Pearson (PK) share price?
Pearson (PK) has traded in the range of US$ 11.80 to US$ 16.1666 during the past year
What is the PE ratio of Pearson (PK)?
The price to earnings ratio of Pearson (PK) is 22.81
What is the cash to sales ratio of Pearson (PK)?
The cash to sales ratio of Pearson (PK) is 2.35
What is the reporting currency for Pearson (PK)?
Pearson (PK) reports financial results in GBP
What is the latest annual turnover for Pearson (PK)?
The latest annual turnover of Pearson (PK) is GBP 3.67B
What is the latest annual profit for Pearson (PK)?
The latest annual profit of Pearson (PK) is GBP 378M
What is the registered address of Pearson (PK)?
The registered address for Pearson (PK) is 80 STRAND, LONDON, WC2R 0RL
What is the Pearson (PK) website address?
The website address for Pearson (PK) is plc.pearson.com/en-gb
Which industry sector does Pearson (PK) operate in?
Pearson (PK) operates in the PRINTING,PUBLISHING & ALLIED sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CRGPCalissio Resources Group Inc (CE)
US$ 0.0004
(39,900.00%)
20k
SMMESmartMetric Inc (PK)
US$ 0.0001
(9,900.00%)
1.25M
NEOMNeoMedia Technologies Inc (CE)
US$ 0.0001
(9,900.00%)
534.97k
RRGIReality Racing Inc (CE)
US$ 0.0001
(9,900.00%)
209k
ELIQQElectriq Power Holdings Inc (CE)
US$ 0.0001
(9,900.00%)
290
IBKKFImining Technologies Inc (CE)
US$ 0.000001
(-100.00%)
100
EGIOQEdgio Inc (CE)
US$ 0.000001
(-99.99%)
905
CYBFCyberfort Software Inc (CE)
US$ 0.000001
(-99.88%)
20k
CHMJDWaverunner Capital Inc
 0.0045
(-99.40%)
106
CCTLCoin Citadel (PK)
US$ 0.000001
(-99.00%)
108k
HMBLHUMBL Inc (PK)
US$ 0.0009
(0.00%)
359.72M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.00015
(50.00%)
194.9M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.00375
(-1.32%)
188.36M
TSOITherapeutic Solutions International Inc (PK)
US$ 0.0002
(-33.33%)
168.26M
PHILPHI Group Inc (PK)
US$ 0.00025
(-16.67%)
129.87M

Discussion

View Full Feed
gfp927z gfp927z 4 minutes ago
>>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall
ABT
gfp927z gfp927z 5 minutes ago
>>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall
ABT
georgebailey georgebailey 5 minutes ago
Steady I think the rubber hits the road when we see the MHRA label assignment on L. Based on safety, phase 3 and RWE we just might see a broad scope label which I’ll call a home run.
NWBO
Birdbrain Ideas Birdbrain Ideas 6 minutes ago
If what you suggest is a possibility, I would view the early December "Investor's Day" in hindsight as more of a dog and pony show for potential buyers. At this point, investors have been beaten to the point that most of us would accept if the company was sold for $6 or $7 a share. What would that b
AMRN
devil dog 96 devil dog 96 8 minutes ago
In October of 2023 The best setup in the OTC challenge was posted and ATMH still holds the #1 spot! Not one ticker has been found with a better setup! 🏆️

If anyone wants to take the challenge and prove me wrong here is the link https://investorshub.advfn.com/b
ATMH
3jack 3jack 8 minutes ago
We know who you are!
AVXL
gfp927z gfp927z 9 minutes ago
>>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari
ISRG
3jack 3jack 9 minutes ago
We know who you are!
AVXL
gfp927z gfp927z 9 minutes ago
>>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari
ISRG
Lazerator Lazerator 12 minutes ago
Not "walking dead", just dead. I just wish they'd declare bankruptcy instead of pretending like it's going to trade again.
Lazerator Lazerator 13 minutes ago
Clearly, Port turned out to be the fool. Actually, he made fools of all you guys who bought into his scam.
imho imho 13 minutes ago
In the comment section of this article,
https://seekingalpha.com/article/4748984-playing-the-odds-of-anavex-alzheimers-drug-approval#scroll_comments

Someone named Stephen Ayers in his Saturday, 12:42PM comment, says

I asked ChatGPT why the following statement, w
AVXL
Ryoko Ryoko 14 minutes ago
It's not going to be audited. They lied again. They do that once a year. Been that way for the last 4 years.
IBGR
axelvento axelvento 17 minutes ago
has announced that it will be paying its dividend of $0.43 on the 7th of March, an increased payment from last year's comparable dividend. This makes the dividend yield 6.5%, which is above the industry average

$PFE
PFE
Steady_T Steady_T 19 minutes ago
You might be correct about the size of the GBM market in the UK. However you are missing the point.

Approval in the UK validates the MOA and the potential of treating other solid cancers. That will have much more impact than the limited size of the UK market.

Approval
NWBO
skitahoe skitahoe 20 minutes ago
While I'd love you to be right, that would represent over a $14 billion market cap, I believe that's high until the EDEN is available for production of the vaccine. I just don't believe that enough vaccine can be produced in Sawston to justify that market cap until they can make more, which require
NWBO
Saving Grace Saving Grace 20 minutes ago
Putz: We are not at 2 years. Who's we? LoL SMH

Keep an eye on the door. Big revelation! It's coming. UK
NB
elks elks 21 minutes ago
Thanks.
RDAR
commdude commdude 21 minutes ago
I purchased some MJLink stocks a few years ago via their web portal. I assume they are pretty much worthless now, or????  

It wasn't a large investment, and just crossed my mind that I have them after revisiting this forum.
WDLF
TradingCharts TradingCharts 23 minutes ago
Page 2 Signed July 26, 2024

https://cases.stretto.com/public/X063/10210/PLEADINGS/1021007262480000000235.pdf
7. Stalking Horse. The Trustee has demonstrated a sound business justification for
the Court to approve (i) Meteor Energy, LLC or its designee as the Stalking
IBATF
Steady_T Steady_T 26 minutes ago
Good article with a positive slant. It did touch on the potential negatives to give some balance.

Hopefully that is enough depth to generate some interest in Anavex. He did make clear that the approval is likely to be late in the year.

At this point I see a lot of vola
AVXL
axelvento axelvento 27 minutes ago
Why Is There No Vaccine For Norovirus As It Spreads Across US? How Much Do You Need To Wait ?
Among the most promising is the vaccine candidate from Moderna—currently being tested in human participants, says Health.com

https://www.timesnownews.com/health/why-is-there-no-vaccine
MRNA
Oleblue Oleblue 27 minutes ago
D-Wave Announces 2024 Bookings and First On-Premise Advantage System Sale

Capital Markets, Quantum Computing Business

Cierra Choucair
January 10, 2025

D-Wave Quantum Inc. reported fiscal year 2024 bookings exceeding $23 million, a
QBTS
fuagf fuagf 28 minutes ago
You have to be right, when it comes to money and power Musk has everything Trump wants. Wondering what Bannon could have up his sleeve, going out on a limb about keeping Musk out of the White House as he did. Just fell asleep for some two hours. Good break, but always feel lousy after.

Your Recent History

Delayed Upgrade Clock